AmoyDx® Multi-Gene Mutations Detection Kit is a real-time PCR assay. The kit enables qualitative detection of up to 118 variants across 9 genes (KRAS, NRAS, BRAF, PIK3CA, ROS1, RET, HER2, ALK and EGFR). It is designed to assist in identifying clinically relevant biomarkers for patients with non-small cell lung cancer (NSCLC) who may be eligible for approved targeted therapies. The kit is for in vitro diagnostic use and intended for use by trained professionals in a laboratory environment.